Cargando...
Mirogabalin and emerging therapies for diabetic neuropathy
There are currently no approved disease-modifying therapies for diabetic neuropathy, and there are only 3 US Food and Drug Administration-approved therapies (pregabalin, duloxetine, and tapentadol) for painful diabetic neuropathy. They each have moderate efficacy with adverse effects limiting optima...
Gardado en:
| Publicado en: | J Pain Res |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Dove Medical Press
2018
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6110292/ https://ncbi.nlm.nih.gov/pubmed/30174455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JPR.S145999 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|